News | January 28, 2025
RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr
RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024
RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
RPG Life Sciences has reported total income of Rs. 167.79 crores during the period ended June 30, 2024
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Subscribe To Our Newsletter & Stay Updated
